華潤微(688396.SH):子公司轉讓矽磐微電子(重慶)195萬美元股權和105萬美元股權
格隆匯 8 月 16日丨華潤微(688396.SH)公佈,公司全資子公司華潤微電子控股有限公司將所持有的矽磐微電子(重慶)有限公司195萬美元股權和105萬美元股權(分別佔矽磐微電子(重慶)有限公司總股本的6.5%和3.5%)分別以196.1505萬美元等值人民幣和105.6195萬美元等值人民幣(根據交割當日中國人民銀行公佈的人民幣匯率中間價計算)對價轉讓給潤科(上海)股權投資基金合夥企業(有限合夥)和珠海矽盛投資諮詢合夥企業(有限合夥)。
矽磐微電子(重慶)有限公司其他股東已同意以上轉讓事項並同意就以上轉讓對應的股權放棄優先購買權,以上交易不構成重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.